EcoDrugPlus

Insulin Receptor

Ensembl ID : ENSFHEG00000009349
Gene Symbol: INSR
3 Cross references
230 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSFHEG00000005985
Gene Symbol: LOC105936814
3 Cross references
201 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSFHEG00000004520
Gene Symbol: LOC105933955
3 Cross references
206 Possible Orthologues:

Integrin Alpha-5

Ensembl ID : ENSFHEG00000006824
Gene Symbol: LOC105935232
3 Cross references
206 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSFHEG00000014330
Gene Symbol: LOC105930938
3 Cross references
230 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSFHEG00000013072
Gene Symbol: LOC105932724
3 Cross references
204 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSFHEG00000009755
Gene Symbol: ITGA4
3 Cross references
226 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSFHEG00000016808
Gene Symbol: ITGA5
3 Cross references
196 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSFHEG00000001553
Gene Symbol: ITGAV
3 Cross references
238 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSFHEG00000019398
Gene Symbol: ITGB1
3 Cross references
209 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSFHEG00000009530
Gene Symbol: ITGB3
3 Cross references
195 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSFHEG00000013494
Gene Symbol: ITGB5
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).